Notice of Intent to Award Sole Source - Beckman Culture Cost Per Reportable Results (Supply)
ID: 24-RHCO-C-343Type: Special Notice
Overview

Buyer

DEPT OF DEFENSEDEPT OF THE ARMYW40M USA HCAJBSA FT SAM HOUSTON, TX, 78234-4504, USA

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413)

PSC

IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS (6550)

Original Source

https://sam.gov/opp/45bff50f7d0d4bcabbe16d2044c2a42b/view
Timeline
    Description

    The Department of Defense, specifically the Fort Cavazos Health Contracting Cell, intends to award a sole source contract to Beckman Coulter Inc. for the procurement of Cost Per Reportable Results (CPRR) utilizing their urinary analyzers at the Carl R. Darnall Army Medical Center in Fort Cavazos, Texas. This procurement is essential due to the outdated and inaccurate performance of existing analyzers, necessitating FDA-approved equipment that can conduct comprehensive analyses of multiple body fluids to enhance laboratory efficiency. The anticipated contract value is approximately $668,339, with the award expected on or about September 9, 2024. Interested parties may contact Perry J. Cannon at perry.j.cannon.civ@health.mil for further information.

    Point(s) of Contact
    Perry J. Cannon
    perry.j.cannon.civ@health.mil
    Files
    Title
    Posted
    JA Sole Source FAR Part 13.5_Redacted.pdf
    The document outlines a Sole Source Justification and Approval for a procurement by the Fort Cavazos Health Contracting Branch aimed at acquiring Cost Per Reportable Results (CPRR) from Beckman Coulter for urinary analyzers at the Carl R. Darnall Army Medical Center in Fort Hood, TX. The justification highlights the necessity of FDA-approved equipment due to the outdated status of existing analyzers, which are not performing accurately. The procurement will involve a contract covering equipment use and maintenance, based on a monthly usage fee for specific reportables. Beckman Coulter's analyzers are uniquely qualified to conduct comprehensive analyses of multiple body fluids, thereby streamlining laboratory processes. Market research indicated that no other suppliers met the stringent requirements, leading to the conclusion that there was no viable competition. The anticipated contract cost totals $668,339, with funding contingent on availability, underscoring the government's commitment to acquiring specialized healthcare technology while ensuring compliance with federal regulations regarding sole source procurement.
    Similar Opportunities
    CHEMISTRY AND IMMUNOASSAY TESTING PROGRAM
    Active
    Dept Of Defense
    Special Notice DEPT OF DEFENSE is planning to issue a sole source award contract to Roche Diagnostics Corporation for the Chemistry and Immunoassay Testing Program. This program is intended to sustain the use of three Chemistry and Immunochemistry Systems under a Cost Per Reportable Result (CPRR) agreement or Cost Per Reagent Pack. The program includes equipment, reagents, tools, materials, training, and a water purification system, Uninterruptible Power Supply (UPS), and services necessary to meet the Chemistry and Immunochemistry testing and analysis requirements for Walter Reed National Military Medical Center (WRNMMC) laboratories. The anticipated period of performance is five years.
    Microbial Testing Supplies - Bridge Contract
    Active
    Dept Of Defense
    The Department of Defense, specifically the Department of the Army, is seeking to award a sole-source bridge contract for microbial testing supplies to Biomerieux Inc., covering the period from October 1, 2024, to September 30, 2025. This procurement is essential for the William Beaumont Army Medical Center Laboratory, as it involves leasing a microbial identification analyzer and a mass spectrometer, along with necessary reagents and middleware/server interface provision. The unique requirements for ATO authorization on DHA networks necessitate this sole-source approach, as Biomerieux is the only contractor capable of meeting these needs without service disruption. Interested parties can contact Troy Loge at troy.a.loge.civ@health.mil or Robyn Villafranco at Robyn.A.Villafranco.civ@health.mil for further details, with the total contract value estimated at $213,334.67.
    Kidney Reagents for Luminex 3D Analyzer
    Active
    Dept Of Defense
    The Defense Health Agency (DHA) intends to award a sole source contract for Kidney Reagents for the Luminex 3D Analyzer, specifically for the Kidney Transplant Clinic at The Walter Reed National Military Medical Center in Bethesda, Maryland. The procurement aims to secure molecular and serological reagents from One Lambda Inc. that are essential for transplant testing, ensuring compatibility and reducing the risk of organ rejection between donors and recipients. These reagents are critical as they have been validated by the American Society of Histocompatibility and Immunogenetics (ASHI) and are necessary for maintaining the accreditation of the Immunology Lab. Interested parties may express their interest and provide a capability statement to Barbara Sonnier at barbara.n.sonnier.civ@health.mil by September 24, 2024, at 10:00 PM EST.
    Hematology System Cost Per Reportable
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Health Agency, is seeking proposals for the procurement of two fully automated Hematology Systems for the 633rd Medical Group at Langley AFB, Virginia. The systems must perform a range of hematology tests, including complete blood counts and body fluid analyses, while integrating seamlessly with the existing Laboratory Information System (LIS). This procurement is crucial for enhancing operational efficiency in military healthcare, ensuring compliance with regulatory standards, and providing high-quality laboratory services. Interested contractors must submit their proposals electronically by September 20, 2024, and direct any questions to Karl Molina at karl.o.molina.civ@health.mil by September 12, 2024.
    Q301--Abbott I-Stat Cost Per Test for Creatinine and Troponin Testing
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) intends to award a Firm-Fixed priced contract to Abbott Laboratories, Inc. for the procurement of services related to creatinine and troponin testing at the VA North Texas Health Care System. This contract will cover the cost per test reagent agreement, including the supply of i-STAT instruments, associated services, and necessary supplies, with the stipulation that only Abbott's trained technicians will perform the required services due to the proprietary nature of the equipment. The arrangement is crucial for maintaining operational integrity and ensuring timely patient care, as switching suppliers would not be cost-effective and could disrupt laboratory services at the Dallas VA Medical Center. For further inquiries, interested parties can contact Contract Specialist Joshua Weisman at joshua.weisman@va.gov or (432) 213-7094.
    6640--Benchtop flow cytometer Intent to Sole Source
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, specifically the Network Contracting Office 6, intends to award a sole source Firm-Fixed-Price purchase order for an Accuri C6 Plus system from Becton, Dickinson and Company (BD Biosciences). This procurement is aimed at acquiring specialized instruments intended solely for research purposes, not for diagnostic or therapeutic use, highlighting the need for proprietary equipment in the VA's operational framework. Interested parties are invited to demonstrate their capability to meet this requirement by submitting supporting evidence by September 20, 2024, at 4 PM EST, with all inquiries directed to Contracting Officer Jamie Sullivan via email at jamie.sullivan4@va.gov.
    Notice of Intent to Sole Source - Ortho-Clinical Blood Cards Reagent -
    Active
    Dept Of Defense
    The Department of Defense, specifically the Army Health Contracting Activity, intends to award a sole source contract to Ortho-Clinical Inc. for the procurement of red blood cell reagent cards necessary for the Government-owned Ortho Vision ID-MTS Workstation analyzer at Irwin Army Community Hospital in Fort Riley, Kansas. This procurement is classified as sole source due to the unique proprietary nature of the required supplies, which are exclusively produced by Ortho Clinical Diagnostics and have a short expiration period, necessitating timely acquisition. The contract is expected to be awarded on or about September 17, 2024, with funding anticipated from FY 2025, and interested parties may direct inquiries to Perry J. Cannon at perry.j.cannon.civ@health.mil.
    Notice of Intent to Sole-Source - Hematology Analyzer Services
    Active
    Dept Of Defense
    The Department of Defense, specifically the 341st Contracting Squadron at Malmstrom Air Force Base in Montana, intends to award a sole-source contract to Sysmex America, Inc. for routine preventative maintenance services and reagents for the Sysmex Hematology Analyzer Unit. This procurement is critical as the analyzer requires specific reagents that are exclusively provided by Sysmex America, making them the only viable source for fulfilling this requirement. Interested parties may submit a capability statement or proposal demonstrating why competitive bidding would be advantageous, with submissions due by 14 October 2024 at 2:00 PM MST. For further inquiries, contact SSgt Kevin Luccitti at kevin.luccitti@us.af.mil or SSgt Joshua Crist at joshua.crist.1@us.af.mil.
    RapidComm
    Active
    Dept Of Defense
    Sources Sought DEPT OF DEFENSE (DEPT OF THE ARMY) is seeking potential sources to provide upgrades and updates to the RapidComm system for continued data management services for Point of Care Testing (POCT) throughout Brooke Army Medical Center (BAMC). The system must have B2B with remote access for updates/upgrades/troubleshooting and possess software capable of operating in the Department of Defense (DoD) network environment. It must support Active Directory integration for username/password compliance and have the ability to manage patient results, quality control, certifications, devices, and device configurations. The system should be user-friendly with an easy-to-use interface and the ability to export data to various formats. It must also have quick view result exception, device alarms, connectivity, and verification of operator status. Additionally, it should be capable of interfacing with various POCT devices. The response due date for this Sources Sought Notice is 4:00 PM CST, 15 December 2023. For more information, contact YaKita McClurkin at yakita.s.mcclurkin.civ@health.mil.
    Scott AFB Hematology Analyzer Lease
    Active
    Dept Of Defense
    The Defense Health Agency (DHA) is soliciting quotes for the lease of a fully automated hematology analyzer at Scott Air Force Base, Illinois, with a contract period from October 1, 2024, to September 30, 2025, and options for two additional years. The procurement aims to provide the 375th Medical Group with a hematology analyzer capable of performing complete blood counts (CBC) and reticulocyte counts, along with an Uninterrupted Power Source (UPS) to ensure continuous operation. This equipment is crucial for delivering high-quality laboratory testing services to military personnel, supporting effective health services within the Department of Defense. Interested vendors must submit their quotes electronically by September 23, 2024, and can direct inquiries to Christopher Comish at christopher.j.comish.civ@health.mil or by phone at 210-952-8620.